Gary R. Lichtenstein, MD
Professor of Medicine
University of Pennsylvania School of Medicine
Director, Center for Inflammatory Bowel Disease
University of Pennsylvania Health System
This activity targets healthcare gaps related to diagnosis and management of Clostridioides difficile infection (CDI), impacting risk of disease transmission through timeliness, consistency, and appropriateness of intervention.
- By addressing these gaps, you can assess whether your approach to symptom evaluation in identifying patients appropriate for CDI screening and treatment, as well as utilization of current treatment guidelines – could be modified to help close these gaps.
- Expert discussion will guide you identifying populations at risk and whether screening is indicated, utilizing evidence-based testing methodologies and optimizing treatment approaches based on CDI episode.
- You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to disease pathophysiology, transmission and treatment.
This educational activity is intended for gastroenterologists, infectious disease specialists, hospitalists, and primary care clinicians involved in the management of patients with Clostridioides difficile infections (CDI).
After completing the CME activity, learners should be better able to:
- Identify Clostridioides difficile infection (CDI) in patients who present with symptoms suggestive of the condition
- Outline evidence-based approaches, including better antimicrobial stewardship, for initial episodes of CDI
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with CDI or those with symptomatology suggestive of CDI that would benefit from timely recognition and intervention.
Credits: 1.0 ANCC Contact Hour
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education for RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Gary R. Lichtenstein, MD; reports the following disclosures:
|Research Support||Celgene, Prometheus Laboratories, Inc., Pfizer Pharmaceuticals, Salix Pharmaceuticals/Valeant, Takeda, UCB, Janssen Orthobiotech|
|Consultant||Abbvie, Cellceutix, Celgene, Eli Lilly, Ferring, Gilead, Janssen Orthobiotech, Luitpold/American Regent, Merck, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals/Valeant, Santarus/Receptos, Shire Pharmaceuticals, Takeda, UCB, Morphic Therapeutics, Endo Pharmaceuticals|
|Honorarium Recipient||Ironwood, Luitpold/American Regent (CME programs), Merck (CME Program), American College of Gastroenterology, Romark, Springer Science and Business Media|
|Editorial Board Involvement||Gastroenterology and Hepatology, American Journal of Gastroenterology, Springer Science and Business Media|
|Other Financial Material Support||American College of Gastroenterology (American Journal of Gastroenterology – IBD Associate Editor), SLACK, Inc. (book royalty), Janssen Orthobiotech (IBD fellowship funding), Springer (book royalty), Takeda (grant and IBD fellowship funding), Pfizer (IBD fellowship funding), Up To Date (author), Eli Lilly (DSMB member)|
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures;
- Participate in the enduring activity; and
- Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making skills before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
RELEASE DATE: October 26, 2020
EXPIRATION DATE: October 26, 2021
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.